WCN26-5302 ROS-Responsive Nanoparticles Mediate Rhein Release to Reprogram Macrophages for Attenuating Acute Kidney Injury

Read full text Summarise with VIRAT
Authors: Meicen Wu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Acute Kidney Injury (AKI) is a critical condition affecting 10-15% of hospitalized patients globally (>50% in ICU) and 3-8% in China (>20% in ICU). The treatment of AKI faces challenges due to limited drug penetration caused by pathological barriers and charge selectivity. Rhein, a natural compound with potent anti-inflammatory effects targeting NF-κB pathways, is limited by poor solubility, low bioavailability, and hepatotoxicity with long-term use.

Fields of Study & Subjects

Acute Kidney Injury Research Nanoparticle-Based Drug Delivery Chemotherapy-induced organ toxicity mitigation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103985–103985
Publication date
25 March 2026
Language
EN